Thomson Horstmann & Bryant Inc. trimmed its holdings in Cardiovascular Systems Inc (NASDAQ:CSII) by 4.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 179,218 shares of the medical device company’s stock after selling 8,307 shares during the period. Thomson Horstmann & Bryant Inc. owned approximately 0.51% of Cardiovascular Systems worth $5,105,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in the stock. Prudential Financial Inc. grew its stake in Cardiovascular Systems by 1.5% in the 4th quarter. Prudential Financial Inc. now owns 32,495 shares of the medical device company’s stock valued at $926,000 after buying an additional 471 shares in the last quarter. NJ State Employees Deferred Compensation Plan boosted its holdings in Cardiovascular Systems by 11.1% in the 4th quarter. NJ State Employees Deferred Compensation Plan now owns 10,000 shares of the medical device company’s stock valued at $285,000 after purchasing an additional 1,000 shares during the period. Quantamental Technologies LLC bought a new position in Cardiovascular Systems in the 4th quarter valued at $37,000. Diversified Trust Co boosted its holdings in Cardiovascular Systems by 16.4% in the 4th quarter. Diversified Trust Co now owns 9,950 shares of the medical device company’s stock valued at $283,000 after purchasing an additional 1,400 shares during the period. Finally, Dynamic Technology Lab Private Ltd boosted its holdings in Cardiovascular Systems by 16.1% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 13,658 shares of the medical device company’s stock valued at $535,000 after purchasing an additional 1,896 shares during the period. Institutional investors and hedge funds own 80.59% of the company’s stock.
Get Cardiovascular Systems alerts:Shares of NASDAQ:CSII opened at $40.26 on Friday. The company has a quick ratio of 3.88, a current ratio of 4.38 and a debt-to-equity ratio of 0.15. Cardiovascular Systems Inc has a one year low of $20.89 and a one year high of $41.13. The firm has a market capitalization of $1.40 billion, a price-to-earnings ratio of 805.20 and a beta of 2.09.
Cardiovascular Systems (NASDAQ:CSII) last announced its quarterly earnings results on Wednesday, January 30th. The medical device company reported $0.01 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.04) by $0.05. Cardiovascular Systems had a net margin of 0.74% and a return on equity of 1.28%. The firm had revenue of $60.21 million during the quarter, compared to the consensus estimate of $59.66 million. On average, equities analysts expect that Cardiovascular Systems Inc will post -0.1 earnings per share for the current fiscal year.
Several brokerages have commented on CSII. BidaskClub raised shares of Cardiovascular Systems from a “buy” rating to a “strong-buy” rating in a report on Tuesday, February 5th. ValuEngine raised shares of Cardiovascular Systems from a “buy” rating to a “strong-buy” rating in a report on Tuesday. Finally, Zacks Investment Research reissued a “hold” rating on shares of Cardiovascular Systems in a report on Monday, November 12th. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and two have given a strong buy rating to the company’s stock. Cardiovascular Systems has an average rating of “Buy” and a consensus target price of $47.50.
TRADEMARK VIOLATION NOTICE: “Thomson Horstmann & Bryant Inc. Sells 8,307 Shares of Cardiovascular Systems Inc (CSII)” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/4209865/thomson-horstmann-bryant-inc-sells-8307-shares-of-cardiovascular-systems-inc-csii.html.
Cardiovascular Systems Company Profile
Cardiovascular Systems, Inc is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. Its products are primarily catheter-based platforms capable of treating a range of vessel sizes and plaque types.
Further Reading: Momentum Investing
Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems Inc (NASDAQ:CSII).
No comments:
Post a Comment